JSC IC Allianz:企業の戦略・SWOT・財務分析

◆英語タイトル:JSC IC Allianz - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3989
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ロシア
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

JSC IC Allianz – Strategy, SWOT and Corporate Finance Report
Summary

JSC IC Allianz – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

JSC IC Allianz (IC Allianz) a subsidiary of Allianz New Europe Holding GmbH, a division of Allianz SE, is an insurance company. The company offers a range of life and non-life insurance products to both individuals and business customers. The company’s offerings include property insurance, travel insurance, obligatory motor third party liability insurance, civil liability insurance, health insurance, voluntary medical insurance, corporate life insurance, pension insurance, agriculture insurance, annuities, employees insurance, motor own damage insurance, cargo insurance, and liability insurance. IC Allianz has reinsurance contracts with Swiss Re, Hannover Re, and Allianz SE. It distributes its products through a network of branch offices. IC Allianz is headquartered in Moscow, Russia.

Scope

- Detailed information on JSC IC Allianz required for business and competitor intelligence needs
- A study of the major internal and external factors affecting JSC IC Allianz in the form of a SWOT analysis
- An in-depth view of the business model of JSC IC Allianz including a breakdown and examination of key business segments
- Intelligence on JSC IC Allianz’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about JSC IC Allianz, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of JSC IC Allianz and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess JSC IC Allianz as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on JSC IC Allianz’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
JSC IC Allianz: Company Overview
JSC IC Allianz: Overview and Key Facts
JSC IC Allianz: Overview
JSC IC Allianz: Key Facts
JSC IC Allianz: Key Employees
JSC IC Allianz: Major Products and Services
JSC IC Allianz: Company History
JSC IC Allianz: Locations and Subsidiaries
JSC IC Allianz: Key Competitors
JSC IC Allianz: Company Analysis
JSC IC Allianz: Business Description
JSC IC Allianz: SWOT Analysis
JSC IC Allianz: SWOT Overview
JSC IC Allianz: Strengths
JSC IC Allianz: Weaknesses
JSC IC Allianz: Opportunities
JSC IC Allianz: Threats
JSC IC Allianz: Recent Developments
JSC IC Allianz: News and Events Summary
JSC IC Allianz: Financial Deals
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: JSC IC Allianz: Key Facts
Table 2: JSC IC Allianz: Key Employees
Table 3: JSC IC Allianz: Company History
Table 4: JSC IC Allianz: Locations and Subsidiaries
Table 5: JSC IC Allianz: Key Competitors
Table 6: JSC IC Allianz: News and Events Summary
Table 7: JSC IC Allianz: Financial Deals

★海外企業調査レポート[JSC IC Allianz:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sibur Holding:石油・ガス:M&Aディール及び事業提携情報
    Summary Sibur Holding (Sibur) is a vertically integrated gas processing and petrochemicals company. Sibur is one of the major players in Russian petrochemical industry delivering large volumes of associated petroleum gas. The company offers liquefied petroleum gas, natural gas, naphtha and natural g …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務分析
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Johnston Press plc:企業の戦略的SWOT分析
    Johnston Press plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Mitteldeutsche Braunkohlengesellschaft mbH:企業の戦略的SWOT分析
    Mitteldeutsche Braunkohlengesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Monica Healthcare Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Monica Healthcare Ltd (MHL), a subsidiary of GE Healthcare LLC, is a medical device company that develops and commercializes fetal monitoring devices for use during labor and uterine activity applications. The company provides products such as monica AN24 with IF24, monica AN24 with VS progr …
  • Tenneco Inc (TEN):企業の財務・戦略的SWOT分析
    Tenneco Inc (TEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CEL-SCI Corp (CVM)-製薬・医療分野:企業M&A・提携分析
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • TransAtlantic Petroleum Ltd (TAT):企業の財務・戦略的SWOT分析
    TransAtlantic Petroleum Ltd (TAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sing Investments & Finance Ltd (S35):企業の財務・戦略的SWOT分析
    Sing Investments & Finance Ltd (S35) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Phosplatin Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Phosplatin Therapeutics LLC (Phosplatin Therapeutics) is a drug development company that carries out the clinical development of phosphaplatins products. The company develops small-molecule compounds which are used for the treatment of cancer. It has collaborations with various contract rese …
  • Bonnier AB:企業の戦略的SWOT分析
    Bonnier AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Lipocine Inc (LPCN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Zhejiang Huahai Pharmaceutical Co Ltd (600521):企業の財務・戦略的SWOT分析
    Zhejiang Huahai Pharmaceutical Co Ltd (600521) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Techniker Krankenkasse:企業の戦略的SWOT分析
    Techniker Krankenkasse - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • HeartWare International Inc:企業の戦略的SWOT分析
    HeartWare International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Martin Midstream Partners L.P.:企業のM&A・事業提携・投資動向
    Martin Midstream Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Martin Midstream Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. The company’s lead product DCR-PHXC is used for the treatment of primary hyperoxaluria (PH). It offers RNAi technology platf …
  • Standard Chem & Pharm Co Ltd:企業の戦略・SWOT・財務分析
    Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • United Company RUSAL Plc:企業の戦略・SWOT・財務情報
    United Company RUSAL Plc - Strategy, SWOT and Corporate Finance Report Summary United Company RUSAL Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆